<DOC>
	<DOCNO>NCT00819663</DOCNO>
	<brief_summary>Anti-TNF therapy induces intestinal wall remodel correlate clinical response detect patient undergo serial compute tomography enterography ( CTE ) .</brief_summary>
	<brief_title>Intestinal Wall Remodeling ( Infliximab Therapy ) Crohn 's Disease Patients Undergoing Serial Computed Tomography ( CT ) Enterography</brief_title>
	<detailed_description>We retrospectively identify Crohn 's disease patient underwent serial CTE imaging 2004 2008 . Approximately 4500 CTEs perform period . We estimate sample size 50 Crohn 's disease patient CTE perform infliximab therapy initiate . We analyze CTE presence penetrate disease , number inflammatory lesion , length lesion , severity lesion ( degree enhancement , wall thickness , stratification , vascular engorgement , fatty proliferation , symmetry ) . Degree enhancement thickness grade 5-point scale . Stratification , vascular engorgement , fatty proliferation , symmetry treat dichotomous variable ( yes/no ) . Only small bowel lesion describe . A GI radiologist ( JGF ) , blind clinical information previous imaging result , provide reading . Comparisons CTEs perform determine responder ( lesion improve ) , mixed responder ( lesion improve ) , refractory ( lesion improve ) . A descriptive pattern healing also record lesion . Clinical data record include indication CTE , time CTE , date CTE , date first infliximab infusion , dose infliximab , interval infusion , history penetrate disease , history surgery , clinical status imaging ( remission , flare , uncertain ) , medication usage , age , disease duration . Clinical status time image base order clinician 's global assessment time repeat CTE . This determined review medical record gastroenterologist ( DHB ) .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Infliximab</mesh_term>
	<criteria>Inclusion criterion Established Crohn 's disease CTE initiate infliximab Underwent least 2 CTEs 1/1/2004 12/31/2007 At least 6 month CTEs *offlabel use infliximab either increase dose shorten interval include study Exclusion criterion Small bowel surgery occur repeat CTE image Episodic infliximab therapy ( interval great every 8 week )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>